2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Future Directions in Cancer Research
- Liquid Tumor Models and In Silico Simulations
- Metabolism and Cancer: Novel Therapeutic Targets
- Emerging Trends in Oncolytic Virus Therapy
- Exploring the Role of Microbiome in Cancer
The future of cancer research holds immense promise with advancements in personalized medicine, immunotherapy, and early detection technologies. One of the most exciting directions is the development of targeted therapies, which aim to treat cancer by identifying and attacking specific cancer cells without harming healthy tissue. Immunotherapy, which harnesses the body's immune system to fight cancer, is also showing great potential, especially with innovative approaches like CAR T-cell therapy. Moreover, the integration of artificial intelligence in research is speeding up drug discovery and diagnosis, enabling more accurate predictions and treatment plans. Finally, precision medicine and genetic research are paving the way for individualized cancer treatments, offering hope for better outcomes and more effective therapies in the future.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China